Sponsor Pipeline

MediLink Therapeutics (Suzhou) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
22
Active Trials
17
Recruiting
6
Phase 3
8
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-31 NCT07739758 A Study of YL201 in Combination With Serplulimab in Participants With Treatment-naïve… Phase 3 Not Yet Recruiting
Active Trials by Phase
Phase 3
6
Phase 2
4
Phase 1/2
8
Phase 1
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06629597 A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma Recruiting
NCT07461454 YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast Cancer Locally Advanced or Metastatic Breast Cancer Recruiting
NCT07416994 Pivotal Study to Evaluate YL202 Versus Docetaxel in Patients With Locally Advanced or… Non-Small Cell Lung Cancer Recruiting
NCT07487896 A Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With… Advanced Esophageal Squamous Cell Carcinoma Recruiting
NCT06612151 A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer Small Cell Lung Cancer Active, Not Recruiting
NCT07739758 A Study of YL201 in Combination With Serplulimab in Participants With Treatment-naïve… SCLC, Extensive Stage Not Yet Recruiting
Phase 2
NCT06241846 A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in… Metastatic Castration-resistant Prostate Cancer (mCRPC) Recruiting
NCT06107686 A Study of YL202 in Selected Patients With Advanced Solid Tumors NSCLC Recruiting
NCT07202364 A Study of YL202 in Patients With Advanced Solid Tumors Non Small Cell Lung Cancer Recruiting
NCT06439771 A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of YL202 in… Locally Advanced or Metastatic Breast Cancer Recruiting
Phase 1/2
NCT07169994 A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced… Advanced Solid Tumors Recruiting
NCT07258979 A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in… Recurrent or Metastatic Nasopharyngeal Carcinoma Recruiting
NCT06459973 A Clinical Study of YL205 in Patients With Advanced Solid Tumors Advanced Solid Tumors Recruiting
NCT07197827 A Study of YL242 in Subjects With Advanced Solid Tumors Advanced Solid Tumor Recruiting
NCT07407933 A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With… Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma Recruiting
NCT07208773 A Study of YL201 and Ivonescimab (AK112) in Advanced Solid Tumors Advanced Solid Tumors Recruiting
NCT05434234 A Study of YL201 in Patients With Advanced Solid Tumors Advanced Solid Tumor Recruiting
NCT06057922 A Study YL201 in Patients With Selected Advanced Solid Tumors Advanced Solid Tumor Active, Not Recruiting
Phase 1
NCT06859762 A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors Advanced Solid Tumor Recruiting
NCT06384352 Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced… Advanced Solid Tumors Recruiting
NCT05653752 A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung… Non Small Cell Lung Cancer Active, Not Recruiting
NCT06394414 A Phase 1 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in… Advanced Solid Tumors Active, Not Recruiting
Disease Areas
Get alerts when MediLink Therapeutics (Suzhou) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free